16 Strazzullo P, Galletti F, Barba G. Altered renal handling of sodium in human hypertension: Short review of the evidence. Hypertension,2003, 41: 1000-1005？？
[8]
17 Lippert C, Seeger H, Mueck A O. The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci, 2003, 72: 877-883？？
[9]
18 Freeman S M, Abboud C N, Whartenby K A, et al. The “bystander effect”: Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res, 1993, 53: 5274-5283
[10]
19 Culver K W, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science, 1992, 256: 1550-1552？？
[11]
2 Dong J, Liu W Q, Jiang A M, et al. A novel peptide, selected from phage display library of random peptides, can efficiently target into human breast cancer cell. Chin Sci Bull, 2008, 53: 860-867？？
[12]
3 Dong J, Yang J, Chen M Q, et al. A comparative study of gene vaccines encoding different extracellular domains of the vascular endothelial growth factor receptor 2 in the mouse model of colon adenocarcinoma CT-26. Cancer Biol Ther, 2008, 7: 502-509？？
[13]
4 Heim R, Cubitt A B, Tsien R Y. Improved green fluorescence. Nature, 1995, 373: 663-664
12 Joliot A, Prochiantz A. Transduction peptides: From technology to physiology. Nat Cell Biol, 2004, 6: 189-196？？
[17]
13 Green M, Loewenstein P M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell, 1988, 55: 1179-1188？？
[18]
14 Frankel A D, Pabo C O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 1988, 55: 1188-1193
[19]
15 Doris P A. Renal proximal tubule sodium transport and genetic mechanisms of essential hypertension. J Hypertens, 2000, 18: 509-519？？
[20]
20 Burrow F J, Core M, Smiley W R, et al. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Cancer Gene Ther, 2002, 9: 87-95？？
